It has been hypothesised that increased levels of Gal-3 and IL-1 in patients with COVID-19 may also be involved in the damage leading to the development of Alzheimer’s disease (Cauchois et al., 2020; Tao et al., 2020; Ciaccio et al., 2021). This evidence concerns the gene LGALS3 and COVID-19.